As such, delayed diagnosis may lead to avoidable mortality and morbidity, and it was reported previously that 4% of patients with an apparently sporadic CNS haemangioblastoma and no clinical evidence of VHL disease will have a detectable VHL gene mutation [12]. The gene discussed is VHL; the disease is von Hippel-Lindau disease.